Research Article
Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis
Table 4
Significant differences in SAA concentration between groups of RA patients.
| Variables | SAA (mg/L) | value |
| Gender | | | Male | 433.6 (238.0) | 0.01 | Female | 298.9 (263.6) | Disease activity | | | DAS28 > 5.1 | 478.3 (228.1) | <0.0001 | DAS28 ≤ 5.1 | 261.5 (251.4) | Current GC treatment | | | Positive | 361.1 (261.0) | 0.002 | Negative | 213.0 (0.12) | Carotid plaques | | | Positive | 388.3 (250.6) | 0.04 | Negative | 302.2 (265.7) | Cystatin-C | | | ≥1.0 mg/L | 492.4 (229.2) | 0.004 | <1.0 mg/L | 303.9 (260.4) |
| Only in women | Current biological DMARDs | | | Negative | 332.1 (266.5) | 0.01 | Positive | 210.2 (237.8) |
|
|
Values are mean (SD). DAS: disease activity score; GC: glucocorticoid.
|